USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Jun 30, 2022 (est) | Mar 31, 2022 | $0.11 | $-0.31 | $-0.42 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Jun 30, 2022 (est) | Mar 31, 2022 | $10.02M | $105.03K | $0.00 |
Aditx Therapeutics, Inc's next estimated earnings date (based on same quarter last year's date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $0.44 | $0.44 | $0.44 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $0.44 | $0.44 | $0.44 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $41.74M | $41.74M | $41.74M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2022 | Dec 2021 | $0.23 | $-0.31 | -234.78% |
| Nov 15, 2021 | Sep 2021 | $0.17 | $-0.56 | -429.41% |
| Sep 30, 2021 | Jun 2021 | $-0.05 | $-0.56 | -1023.20% |
| Jun 30, 2021 | Mar 2021 | $-0.21 | $-0.42 | -102.00% |
| Mar 31, 2021 | Dec 2020 | $-0.29 | $-0.46 | -59.07% |
| Dec 31, 2020 | Sep 2020 | - | $-0.38 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.37 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.14 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.30 | - |
| Dec 31, 2019 | Sep 2019 | - | $-0.26 | - |
| Sep 30, 2019 | Jun 2019 | - | $-0.28 | - |
| Jun 30, 2019 | Mar 2019 | - | $-0.67 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.32 | - |
| Dec 31, 2018 | Sep 2018 | - | $-0.14 | - |
| Sep 30, 2018 | Jun 2018 | - | $-0.39 | - |
| Jun 30, 2018 | Mar 2018 | - | $-0.52 | - |
| Mar 31, 2018 | Dec 2017 | - | $-0.52 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2022 | Dec 2021 | $-0.85 | $-1.86 | - |
| Mar 31, 2021 | Dec 2020 | $-0.73 | $-1.35 | - |
| Mar 31, 2020 | Dec 2019 | - | $-1.51 | - |
| Mar 31, 2019 | Dec 2018 | - | $-1.37 | - |
| Mar 31, 2018 | Dec 2017 | - | $-0.52 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2022 | Dec 2021 | $0.00 | $105.03K | - |
| Nov 15, 2021 | Sep 2021 | $4.50M | $0.00 | - |
| Sep 30, 2021 | Jun 2021 | $1.00M | $0.00 | - |
| Jun 30, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | - | $0.00 | - |
| Dec 31, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| Jun 30, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Dec 31, 2019 | Sep 2019 | - | $0.00 | - |
| Sep 30, 2019 | Jun 2019 | - | $0.00 | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Dec 31, 2018 | Sep 2018 | - | - | - |
| Sep 30, 2018 | Jun 2018 | - | - | - |
| Jun 30, 2018 | Mar 2018 | - | - | - |
| Mar 31, 2018 | Dec 2017 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2022 | Dec 2021 | $0.00 | $105.03K | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
| Mar 31, 2018 | Dec 2017 | - | - | - |
ADTX's next estimated earnings date (based on same quarter last year's report date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.
Aditx Therapeutics, Inc's previous earnings date was Mar 31, 2022 for its fiscal quarter ended Dec 31, 2021.
ADTX's earnings per share (EPS) was $-0.31, missing the consensus analysts forecast of $0.23 by -234.78%.
The EPS was higher than the previous fiscal quarter (Sep 2021) by -44.64%, and higher than the same period a year before (Dec 2020) by -32.80%.
Revenues were $105.03K.
The company reported a net income of $-24.05M.Free cash flow for the quarter was $-8.81M , compared to $-4.71M last quarter and $-3.16M a year before.
Aditx Therapeutics, Inc's previous annual earnings date was Mar 31, 2022 for its fiscal year ended Dec 31, 2021.
ADTX's earnings per share (EPS) was $-1.86, missing the consensus analysts forecast of $-0.85 by 118.33% , and lower than the previous year's EPS (Dec 2020) by 37.91%.
Revenues were $105.03K.
The company reported a net income of $-46.37M.
Aditx Therapeutics, Inc reported a free cash flow of $-23.29M for its fiscal year, compared to $-7.39M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
